HOYA Corporation
Research HOYA Corporation (HYB) on Bullrun: valuation model: 18.4% overvalued, market cap EUR 47.62B, P/E 35.3, dividend yield 1.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHYB
- ExchangeF
- CountryJapan
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyEUR
- Valuation signal18.4% overvalued
- Market capEUR 47.62B
- P/E35.3
- Dividend yield1.2%
- Financial periodFY2025
- RevenueEUR 885.82B
- Revenue growth11.8%
- Net incomeEUR 202.10B
- Free cash flowEUR 187.19B
- Gross margin86.5%
Valuation Snapshot
Bullrun's latest valuation model marks HOYA Corporation as 18.4% overvalued; latest market cap is EUR 47.62B; P/E is 35.3; dividend yield is 1.2%.
About HOYA Corporation
HOYA Corporation, a med-tech company, provides high-tech and medical products in the Japan, Asia, the Americas, Europe, and internationally. The company operates through two segments: Life Care, and Information and Communications. It offers life care products, including eyeglasses; contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment;
Frequently asked questions
Is HOYA Corporation overvalued or undervalued?
Bullrun's valuation model currently marks HOYA Corporation as 18.4% overvalued.
What is HOYA Corporation's market cap?
HOYA Corporation's market capitalization is EUR 47.62B.
What is HOYA Corporation's P/E ratio?
HOYA Corporation's price-to-earnings (P/E) ratio is 35.3.
Does HOYA Corporation pay a dividend?
HOYA Corporation has a dividend yield of 1.2%.
What does HOYA Corporation do?
HOYA Corporation, a med-tech company, provides high-tech and medical products in the Japan, Asia, the Americas, Europe, and internationally. The company operates through two segments: Life Care, and Information and Communications. It offers life care products, including eyeglasses; contact lenses;